Evidence map›Paper›PMID 37503136›Full record

ArticlemedRxiv : the preprint server for health sciences2023

The Medical Action Ontology: A Tool for Annotating and Analyzing Treatments and Clinical Management of Human Disease.

Leigh C Carmody, Michael A Gargano, Sabrina Toro, Nicole A Vasilevsky, Margaret P Adam, Hannah Blau, Lauren E Chan, David Gomez-Andres, Rita Horvath, Megan L Kraus and 16 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 15 institutions in 5 countries.

Leigh C CarmodyThe Jackson Laboratory for Genomic Medicine,Farmington,CT,United States.
Michael A GarganoThe Jackson Laboratory for Genomic Medicine,Farmington,CT,United States.
Sabrina ToroUniversity of Colorado Anschutz Medical Campus,Aurora,CO,United States.
Nicole A VasilevskyCritical Path Institute, Tucson, AZ, United States.
Margaret P AdamUniversity of Washington School of Medicine, Seattle, WA, United States.
Hannah BlauThe Jackson Laboratory for Genomic Medicine,Farmington,CT,United States.
Lauren E ChanOregon State University,Corvallis,OR,United States.
David Gomez-AndresPediatric Neurology, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus., Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Rita HorvathDepartment of Clinical Neurosciences, University of Cambridge, Robinson Way CB2 0PY, Cambridge UK.
Megan L KrausUniversity of Colorado Anschutz Medical Campus,Aurora,CO,United States.
Markus S LadewigDepartment of Ophthalmology,Klinikum Saarbrücken,Saarbrücken,Germany.
David Lewis-SmithTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom.
Hanns LochmüllerChildren's Hospital of Eastern Ontario Research Institute.
Nicolas A MatentzogluSemanticly, Athens, Attiki, Greece.
Monica C Munoz-TorresUniversity of Colorado Anschutz Medical Campus,Aurora,CO,United States.
Catharina SchuetzDepartment of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
Berthold SeitzDepartment of Ophthalmology,Saarland University Hospital UKS,Homburg/Saar Germany.
Morgan N SimilukNational Institute of Allergy and Infectious Diseases,National Institutes of Health,Bethesda,MD,United States.
Teresa N SparksDepartment of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143.
Timmy StraussDepartment of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
Emilia M SwietlikDepartment of Medicine, University of Cambridge, Heart and Lung Research Institute, CB2 0BB, Cambridge, UK.
Rachel ThompsonChildren's Hospital of Eastern Ontario Research Institute.
Xingmin Aaron ZhangThe Jackson Laboratory for Genomic Medicine,Farmington,CT,United States.
Christopher J MungallLawrence Berkeley National Laboratory,Berkeley,CA,United States.
Melissa A HaendelUniversity of Colorado Anschutz Medical Campus,Aurora,CO,United States.
Peter N RobinsonThe Jackson Laboratory for Genomic Medicine,Farmington,CT,United States.
Jackson Laboratory · USUniversity of Colorado Anschutz Medical Campus · USChildren's Hospital of Eastern Ontario · CAUniversity Hospital Carl Gustav Carus · DEUniversity of Cambridge · GBCritical Path Institute · USKlinikum Saarbrücken · DELawrence Berkeley National Laboratory · USNational Institutes of Health · USNewcastle University · GBOregon State University · USSaarland University · DEUniversity of California, San Francisco · USUniversity of Washington · USVall d'Hebron Institut de Recerca · ES

Funding

Improvements to the LinkML framework to support the Phenomics First open science resourceRM1HG010860 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2020 to 2024
$10.3M
The Human Phenotype Ontology: Accelerating Computational Integration of Clinical Data for GenomicsU24HG011449 · NHGRI · JACKSON LABORATORY · PI Peter Nicholas Robinson · 2021 to 2026
$6.7M
Medical Research Council G1000848Medical Research Council MR/N025431/2Medical Research Council MR/S005021/1Medical Research Council MR/V009346/1NHGRI NIH HHS RM1 HG010860NHGRI NIH HHS U24 HG011449
6 · The paper itself

Abstract

Navigating the vast landscape of clinical literature to find optimal treatments and management strategies can be a challenging task, especially for rare diseases. To address this task, we introduce the Medical Action Ontology (MAxO), the first ontology specifically designed to organize medical procedures, therapies, and interventions in a structured way. Currently, MAxO contains 1757 medical action terms added through a combination of manual and semi-automated processes. MAxO was developed with logical structures that make it compatible with several other ontologies within the Open Biological and Biomedical Ontologies (OBO) Foundry. These cover a wide range of biomedical domains, from human anatomy and investigations to the chemical and protein entities involved in biological processes. We have created a database of over 16000 annotations that describe diagnostic modalities for specific phenotypic abnormalities as defined by the Human Phenotype Ontology (HPO). Additionally, 413 annotations are provided for medical actions for 189 rare diseases. We have developed a web application called POET (https://poet.jax.org/) for the community to use to contribute MAxO annotations. MAxO provides a computational representation of treatments and other actions taken for the clinical management of patients. The development of MAxO is closely coupled to the Mondo Disease Ontology (Mondo) and the Human Phenotype Ontology (HPO) and expands the scope of our computational modeling of diseases and phenotypic features to include diagnostics and therapeutic actions. MAxO is available under the open-source CC-BY 4.0 license (https://github.com/monarch-initiative/MAxO).

Indexed as

diagnosisMedical Action Ontologyontologyrare diseasetreatment

Identifiers

PMID37503136
PMCPMC10370244
OpenAlexW4384154318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.